0
2021
Influenza Vaccine Market

Influenza Vaccine Market

by Vaccine Type (Quadrivalent and Trivalent), Technology (Egg-based, and Cell culture), Age Group (Pediatric, and Adult), and Route of Administration (Injection, and Nasal Spray): Global Opportunity Analysis and Industry Forecast, 2021-2030
Update Available On-Demand

Report Code: A01118
Pages: 217
Aug 2021 | 23970 Views
Author(s) : Vishal B, Ajinkya A, Shubham C , Omkar S
Tables: 136
Charts: 44
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Influenza Vaccine Market

Request Now !

The global influenza vaccine market size was valued at $5024.60 million in 2020, and is projected to reach $10,127.0 million by 2030, registering a CAGR of 7.20% from 2021 to 2030. The viral infection which occurs due to flu in the respiratory system is called influenza. Influenza virus travels through respiratory droplets and it is contagious. It can also spread from one person to another while talking or due to physical contact. The influenza virus circulates continuously, causing regional epidemics and outbreaks which leads to thousands of deaths. Changing character of the virus is compelling an annual change in the vaccine strain to match the influenza virus strain. Healthcare organizations all over the world like Centers for Disease Control and Prevention (CDC) have suggested vaccines like baloxavir marboxil (Xofluza) for the treatment of influenza have recommended certain influenza vaccines such as baloxavir marboxil (Xofluza) to treat the symptoms in patients.

The COVID-19 outbreak is anticipated to have a positive impact on growth of the global influenza vaccine market. The number of population effected with COVID-19 virus increases, surge the demand for influenza vaccine. The influenza vaccine will not prevent COVID-19, but will decrease the illness, death and hospitalization. According to European Congress of Clinical Microbiology & infectious diseases (ECCMID), in 2021, it was reported that around 75,000 COVID-19 patient having shot of influenza vaccine are less prone to sepsis, stroke and deep vein thrombosis. As per the same source, in 2021, it was observed that flu vaccine may offer protection against COVID-19 virus. The patient suffering from COVID-19, and vaccinated with influenza vaccine are also less likely to admitted in intensive care unit. Subsequently, this leads to increase in demand for influenza vaccine.

The vaccines used for influenza are made up of three different influenza viruses like influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain. Increase in prevalence of influenza epidemics and seasonal outbreaks is likely to expand the product sales during the projected period.

Influenza-Vaccine-market

Increase in government support and surveillance regarding vaccination against influenza on the national and global levels to monitor the supply, distribution, and administration of flu vaccines is one of the crucial factors driving the market growth. Moreover, increase in investment by leading market players across the globe and rise in government funding have facilitated the launch of therapeutically effective vaccines drive the influenza vaccine market growth.

The immunization camps and programs conducted by various healthcare organizations have been affected due to the coronavirus pandemic. Having said that, the rates of the vaccination for flu has reached its peak in the pandemic due to a push by various healthcare operatives and government who are providing free vaccination to the citizens. Awareness has also raised amongst the populations due to the fear of flu and COVID-19.

Influenza Vaccine Market
By Vaccine Type

Your browser does not support the canvas element.

Quadrivalent segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Novel vaccine development is a huge process that generally takes about 10-15 years to develop and establish its safety and efficacy. Regulatory requirements for clinical trials vary in countries, which may delay the development of vaccines which limit the growth of the market.

Many companies like Sanofi, Emergent BioSolutions Inc., and F. Hoffmann-La Roche Ltd, are also helping in the distribution. On the other hand, many countries are facing undersupplies and delay in the approvals of vaccines and availability of vaccines due to the strict regulations during the clinical trials extending the timelines of vaccines delivery.

Influenza Vaccine Market
By Technology

Your browser does not support the canvas element.

Egg-Based segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Global Influenza Vaccine Market Segmentation

The influenza vaccine market is segmented into vaccine type, technology, age group, route of administration and region. By vaccine type, it is divided into quadrivalent and trivalent. By technology, it is classified into egg-based and cell-based. By age group, it is divided into pediatric and adult. By route of administration, it is categorized into injection and nasal spray. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment review

By vaccine type, it is divided into quadrivalent and trivalent. The quadrivalent type segment was the major revenue contributor in 2020, owing to its ability to immunize four influenza virus strains (two A subtypes and two B subtypes — H1N1 and H3N2 and Victoria and Yamagata, respectively). By technology, it is classified into egg-based and cell-based. 

Influenza Vaccine Market
By Age Group

Your browser does not support the canvas element.

Adult segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

The egg-based technology segment dominates the technology segment as it is most commonly used in production of both inactivated and live-attenuated vaccines. By age group, it is bifurcated into pediatric and adult. The adult age group segment was the highest contributor in the influenza vaccine market in 2020 and is expected to remain dominant during the forecast period, owing to higher risks of developing serious complications from influenza due to weaker immune response.  

North America accounted for the largest influenza vaccine market share in 2020 and is expected to retain its dominance throughout the forecast period. This is attributed to the increased prevalence of influenza in the region, increase in government focus on immunization programs, emergence of new vaccines, and growth in technological advancements for vaccine administration. However, Middle East and Africa is expected to emerge as a lucrative area with maximum growth potential, due to the increase in awareness program, improvement in healthcare facilities, available disposable income, and rapid development of economic conditions.

Influenza Vaccine Market
By Route Of Administration

Your browser does not support the canvas element.

Injection segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Some of the key players operating in the influenza vaccine market are AstraZeneca plc., Biodiem, CSL Limited, Emergent BioSolutions, F. Hoffmann-La Roche Ltd., Gamma Vaccines Pty Ltd., GlaxoSmithKline plc, Merck & Co. Inc. (Merck Sharp & Dohme Corp.), Novartis AG, Pfizer, Inc., Sanofi Pasteur SA, and Sinovac Biotech Ltd. 

Influenza Vaccine Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global influenza vaccine market to identify the prevailing opportunities.
  • This study presents the competitive landscape of the global influenza vaccine market to predict the competitive environment across geographies.
  • Comprehensive analysis of factors that drive and restrict the influenza vaccine market growth is provided.
  • Region- & country-wise analysis is provided to understand the influenza vaccine market trends and dynamics

Key Market Segments

By Vaccine Type

  • Quadrivalent
  • Trivalent

By Type

  • Seasonal
  • Pandemic

By Technology

  • Egg-based
  • Cell-based

By Age Group

  • Pediatric
  • Adult 

By Route Of Administration

  • Injection
  • Nasal Spray

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
    • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Key Market Players 

  • Astrazeneca Plc (Astrazeneca)
  • Biodiem
  • Csl Limited (Seqirus GmbH)
  • Emergent Biosolutions
  • F. Hoffmann-La Roche Ltd.
  • Gamma Vaccines Pty Ltd.
  • Glaxosmithkline Plc
  • Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
  • Novartis Ag
  • Pfizer, Inc.
  • Sanofi
  • Sinovac Biotech Ltd.
 

Loading Table Of Content...


 
 

According to analyst perspective, the influenza vaccine industry holds the maximum potential, owing to the increase in R&D activities related to influenza vaccines, growth in immunization programs, and rise in the incidences of influenza globally which, in turn, are responsible to drive the market growth. Furthermore, significant technological advancements in the manufacturing technology of vaccines to improve efficacy and potency of vaccines along with increased investments by manufacturers to upgrade traditional vaccination production and delivery methods contribute to increased profit margins and enhanced operational efficiencies in the production of influenza vaccines, especially in the U.S. Novel vaccine development generally takes about 10-15 years to develop and establish its safety and efficacy which is a huge process and regulatory requirements for clinical trials vary in countries may delay in development of vaccines which is projected to limit the growth of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Influenza Vaccine Market is $5024.60 million in 2020

A. The forcast period for Influenza Vaccine Market is 2021 to 2031

A. The market value of Influenza Vaccine Market in 2030 is $10,127.00 million.

A. The base year is 2020 in Influenza Vaccine Market.

A. Astrazeneca, Biodem Ltd., CSL Ltd., Emergent Biosolutions Ltd., Roche held a high market postion owing to the strong geographical foothold in different regions.

A. Quadrivalent segment dominates the global market, this is attributed to the number of pharmaceutical companies producing this vaccines.

A. The major factor for the growth of Influenza Vaccine Market are high prevalence of influenza, increase in government focus on immunization programs, emerging vaccines and technological progress in vaccine administration.

A. Owing to rise in the number of vaccines available in the market along with government initiatives to improve the immunization programs. Furthermore, government initiatives and technological advancements toward flu is expected to propel the demand for Influenza Vaccine Market in the region.

A. Influenza commonly known as flu is a contagious respiratory infection or illness caused by influenza viruses. The influenza vaccine protects a person from getting the flu.

A. Flu vaccines are designed to protect against the influenza viruses that are predicted to be the most common during the upcoming season.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Influenza Vaccine Market

Start reading instantly.
This Report and over 19,266+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Aug 2022 - Aug 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2022 - Aug 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2022 - Aug 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2022 - Aug 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2022 - Aug 2023)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers